多功能蛋白聚糖(VCAN)多克隆抗体
Polyclonal Antibody to Versican (VCAN)
CSPG2; VS; ERVR; PG-M; WGN1; Chondroitin Sulfate Proteoglycan 2; Chondroitin sulfate proteoglycan core protein 2; Glial hyaluronate-binding; Large fibroblast proteoglycan
- 编号PAB817Mu01
- 物种Mus musculus (Mouse，小鼠)相同的名称，不同的物种。
- 来源多抗制备
- 宿主兔
- 效价-
- Ig类型IgG
- 纯化方式抗原特异性亲和纯化
- 标记物无标记物
- 免疫原RPB817Mu01-多功能蛋白聚糖(VCAN)重组蛋白
- 缓冲液成份磷酸盐缓冲液（pH7.4,含有0.02% NaN3和50%甘油）
- 性状液体
- 浓度0.49mg/ml
- 且适物种-
- 应用WB; IHC; ICC; IP.
如果抗体需用于流式细胞术，请参见流式抗体。 - 下载英文说明书 中文说明书
- 规格20µl100µl200µl1ml10ml
- 价格¥ 616¥ 1436¥ 2052¥ 5130¥ 20520
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
IHC图
Figure. Western Blot; Sample: Recombinant Versican, Mouse.
Figure. Western Blot; Sample: Mouse Heart Tissue.
通过ISO 9001、ISO 13485质量体系认证
特异性
该抗体是针对VCAN的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别VCAN。
用法
Western blotting: 0.01-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
储存
经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
赠品
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPB817Mu02 | 多功能蛋白聚糖(VCAN)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB817Mu01 | 多功能蛋白聚糖(VCAN)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB817Mu01 | 多功能蛋白聚糖(VCAN)多克隆抗体 | WB; IHC; ICC; IP. |
| PAB817Mu02 | 多功能蛋白聚糖(VCAN)多克隆抗体 | WB; IHC; ICC; IP. |
| SEB817Mu | 多功能蛋白聚糖(VCAN)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB817Mu | 多功能蛋白聚糖(VCAN)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Plos one | Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro[PubMed: PMC3570526] |
| Clinica Chimica Acta | Versican and its associated molecules: Potential diagnostic markers for multiple myeloma[Pubmed:25623955] |
| Journal of Cancer Research and Clinical Oncology | Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma[] |
| RNA Biology | Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signaling[Pubmed: 31532704] |
| miR-124-3p and miR-181a-5p Mediate AT1-Receptor Autoantibody Induced Fetal Rat Cardiac Remodeling via Increased VCAN Expression[] |